List of Abivax patents | 5 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11278552 Combinations including ABX196 for the treatment of cancer	Patent 11278552 was granted and assigned to Abivax on March, 2022 by the United States Patent and Trademark Office.	Abivax	Abivax	United States Patent and Trademark Office	11278552	March 22, 2022
‌ US Patent 11266667 ABX196 for use in the treatment of bladder cancer	Patent 11266667 was granted and assigned to Abivax on March, 2022 by the United States Patent and Trademark Office.	Abivax	Abivax	United States Patent and Trademark Office	11266667	March 8, 2022
‌ US Patent 8916164 Methods of enhancing adjuvaticity of vaccine compositions	Patent 8916164 was granted and assigned to Abivax on December, 2014 by the United States Patent and Trademark Office.		Abivax	United States Patent and Trademark Office	8916164	December 23, 2014
‌ US Patent 10870671 Method of preparation of alpha galactosyl ceramides compounds	Patent 10870671 was granted and assigned to Abivax on December, 2020 by the United States Patent and Trademark Office.	Abivax	Abivax	United States Patent and Trademark Office	10870671	December 22, 2020
‌ US Patent 9220767 Vaccine composition for use against influenza	Patent 9220767 was granted and assigned to Abivax on December, 2015 by the United States Patent and Trademark Office.		Abivax	United States Patent and Trademark Office	9220767	December 29, 2015